Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index; 19 of the 76 sources its claims cite were checked for support.

Considerations for addressing bias in artificial intelligence for health equity

Open access
Abràmoff, Michael D., Tarver, Michelle E., Loyo-Berrios, Nilsa, Trujillo, Sylvia, Char, Danton, Obermeyer, Ziad, Eydelman, Malvina B., Foundational Principles of Ophthalmic Imaging and Algorithmic Interpretation Working Group of the Collaborative Community for Ophthalmic Imaging Foundation, Washington, D.C., Maisel, William H. · 2023 · npj Digital Medicine

Abstract

Health equity is a primary goal of healthcare stakeholders: patients and their advocacy groups, clinicians, other providers and their professional societies, bioethicists, payors and value based care organizations, regulatory agencies, legislators, and creators of artificial intelligence/machine learning (AI/ML)-enabled medical devices. Lack of equitable access to diagnosis and treatment may be improved through new digital health technologies, especially AI/ML, but these may also exacerbate disparities, depending on how bias is addressed. We propose an expanded Total Product Lifecycle (TPLC) framework for healthcare AI/ML, describing the sources and impacts of undesirable bias in AI/ML systems in each phase, how these can be analyzed using appropriate metrics, and how they can be potentially mitigated. The goal of these “Considerations” is to educate stakeholders on how potential AI/ML bias may impact healthcare outcomes and how to identify and mitigate inequities; to initiate a discussion between stakeholders on these issues, in order to ensure health equity along the expanded AI/ML TPLC framework, and ultimately, better health outcomes for all.

Overview

CoChat Summary

TL;DR

The paper proposes expanding the Total Product Lifecycle (TPLC) framework to address bias and health equity across all phases of AI/ML-enabled medical devices. It argues that bias can arise or persist at every phase and should be quantified with equity metrics such as subgroup accuracy disaggregation and population-achieved sensitivity/specificity.

Key findings

  • Bias in AI/ML healthcare can exacerbate existing inequities or create new disparities; the paper cites an example where an algorithm intended to identify patients needing extra help actually predicted healthcare costs, resulting in sicker Black patients receiving similar care to healthier White patients despite needing higher acuity care.
  • Equity impact can occur at every TPLC phase and is independent across phases: even when bias is mitigated in earlier phases, a later phase can still introduce undesirable equity effects.
  • Proposed equity metrics include sensitivity disaggregated by demographic subgroup, differential clinical outcome across subgroups, and population-achieved sensitivity/specificity to measure the impact of access and so-called “invisible populations.”
  • Mitigation opportunities include diverse creator teams, racially invariant priors, representative training and validation datasets, diverse clinical sites, and monitoring real-world access, cost, and treatment follow-through.

Methods

  • Conceptual/perspective paper with no empirical study, dataset, or statistical analysis; it synthesizes existing literature and regulatory frameworks, including Char et al., FDA’s TPLC approach, IMDRF, and Good Machine Learning Practice.
  • The authors map TPLC phases—Conception, Design, Development, Validation, Access and marketing, and Monitoring—to sources of bias, equity metrics, and potential mitigation strategies.
  • Analysis is narrative and illustrative, using Fig. 1 examples rather than original data collection or quantitative evaluation.

Limitations

  • The paper states its framework is not intended to be comprehensive for all bias risks and mitigations and is meant to initiate discussion among stakeholders.
  • The paper states it is beyond its scope to exhaustively list metrics for ethics and instead gives examples to illustrate the principle.
  • Evident from the text: the proposed expanded TPLC framework is not empirically validated or quantitatively tested in this paper, and it relies on cited examples and conceptual reasoning.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41746-023-00913-9

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Total Product LifeCycle (TPLC) equity expanded framework with examples for each phase.
Fig. 1 Total Product LifeCycle (TPLC) equity expanded framework with examples for each phase.CC BY · PubMed Central

Verification

Claims the paper makes

11 Valid · 0 Not valid · 30 Not checked · 28 Own results and interpretations

18 more claims

Create a free account to see all 69 claims and to verify the 57 references still open.

See all claims — free account
  • It may state two separate claims as one. 20
  • Probably not a substantial claim. 35

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

8 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 41 references

Research works printed but not linked: 2

  1. American Medical Association. Board of trustees policy summary. Augmented Intelligence In Healthcare. https://www.ama-assn.org/system/files/2019-08/ai-2018-board-policy-summary.pdf (2019).
  2. Chen, I., Johansson, F. D. & Sontag, D. Why is my classifier discriminatory? arXiv 1805, 12002 (2018).

Cited by

See all 350

Metadata

Authors
Abràmoff, M. D., Tarver, M. E., Loyo-Berrios, N., Trujillo, S., Char, D., Obermeyer, Z., Eydelman, M. B., Foundational Principles of Ophthalmic Imaging and Algorithmic Interpretation Working Group of the Collaborative Community for Ophthalmic Imaging Foundation, W., & Maisel, W. H.
Affiliations
  • University of Iowa (US)
  • United States Food and Drug Administration (US)
  • Ochin (US)
  • Stanford Medicine (US)
  • University of California, Berkeley (US)
Corresponding author
Abràmoff, Michael D.
Venue
npj Digital Medicine
Published
2023-09-12
Volume
6
Issue
1
Pages
170-170
ISSN
2398-6352 (ISSN-L)
OpenAlex
W4386637335
Cited by
349
References
41
Citations by year
2026: 106 · 2025: 141 · 2024: 98 · 2023: 4
FWCI
13.47
Type
journal article
Language
en
Open access
Licence
Locations
  • npj Digital Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Physical Sciences › Computer Science › Artificial Intelligence › Ethics and Social Impacts of AI
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
Keywords
algorithmic bias, artificial intelligence in healthcare, health equity, bias mitigation, health disparities, machine learning, digital health technologies, bias metrics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Considerations for addressing bias in artificial intelligence for health equity. https://app.cochat.ai/papers/10.1038/s41746-023-00913-9
The paper
Abràmoff, M. D., Tarver, M. E., Loyo-Berrios, N., Trujillo, S., Char, D., Obermeyer, Z., Eydelman, M. B., Foundational Principles of Ophthalmic Imaging and Algorithmic Interpretation Working Group of the Collaborative Community for Ophthalmic Imaging Foundation, W., & Maisel, W. H. (2023). Considerations for addressing bias in artificial intelligence for health equity. npj Digital Medicine. https://doi.org/10.1038/s41746-023-00913-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.